2-methyl-6-(trifluoromethyl)-3,4-dihydropyrimidin-4-one, 95%, 5g

Hydroxy{[(4-methylphenyl)sulfonyl]oxy}phenyliodine (HTIB), 98.00%, 5g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-(4-(tert-butoxy)phenyl)propanoic acid, 97%, 1g

4-Chloro-2,3-difluoro-5-methoxybenzoic acid, 95%, 500mg

4-(PYRIDIN-2-YLOXY)BENZALDEHYDE HCL, 95.0%, 5g

(S)-Methyl 2-(2-chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino)acetate hydrochloride, 97%, 50g

2-Bromo-1,8-naphthyridine, 97%, 1g

2-Deoxy-3,5-di-O-p-toluoyl-D-erythro-pentofuranosyl chloride, 98%, 5g

(2S,2'S,3S,3'S)-3,3'-Di-tert-butyl-2,2'-dimethyl-2,2',3,3'-tetrahydro-4,4'-bibenzo[d][1,3]oxaphosphole, 97%, 500mg

6-Methylpyrazine-2-carboxylic acid, 95.0%, 10g

4,5-Dibromobenzene-1,2-diamine, 98.0%, 1g

2-(Bromomethyl)-1-fluoro-3-nitrobenzene, 95.0%, 10g

(1-tert-Butoxycarbonyl-piperidin-3-yl)-acetic acid, 95.0%, 1g